<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000662485"><TermName>VAMP regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used with radiation therapy to treat low-risk childhood Hodgkin lymphoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), methotrexate, and prednisone. Also called VAMP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725940" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;VAMP regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725941" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen VAMP&quot;" language="es" id="_4"/><SpanishTermName>régimen VAMP</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el linfoma de Hodgkin infantil de riesgo bajo. Incluye los medicamentos sulfato de vincristina, clorhidrato de doxorubicina (Adriamicina), metotrexato y prednisona. También se llama VAMP.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-05-26</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000719491">VAMP</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
